| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,823,000 | 2,882,000 | 3,118,000 | 3,270,000 | | Cost of Revenue | 3,844,000 |
-
|
-
| 1,408,000 | | | Gross Profit | (1,021,000) | 2,882,000 | 3,118,000 | 1,862,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (2,394,000) | 1,330,000 | 1,227,000 | 59,000 | | Non Recurring | 46,000 | 71,000 | 217,000 | 323,000 | | Others | 367,000 | 360,000 | 355,000 | 396,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 957,000 | 1,121,000 | 1,319,000 | 1,084,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (15,000) | 7,000 | 48,000 | | Earnings Before Interest And Taxes | 959,000 | 1,106,000 | 1,326,000 | 1,132,000 | | Interest Expense | 115,000 | 114,000 | 136,000 | 121,000 | | Income Before Tax | 844,000 | 992,000 | 1,190,000 | 1,011,000 | | Income Tax Expense | 138,000 | 184,000 | 251,000 | 210,000 | | Minority Interest | 4,000 | 1,000 |
-
| (1,000) | | | | Net Income From Continuing Ops | 693,000 | 809,000 | 939,000 | 800,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 710,000 | 809,000 | 939,000 | 800,000 | | Preferred Stock And Other Adjustments |
-
| (3,000) | 3,000 |
-
| | | Net Income Applicable To Common Shares | $710,000 | $806,000 | $942,000 | $800,000 |
|
0.17% Nasdaq 0.00%
Income Statement
